Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erik Boddeke

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Frontiers in Cellular Neuroscience|August 23, 2014
Neuronal CC chemokines: the distinct roles of CCL21 and CCL2 in neuropathic painKnut Biber, Erik Boddeke
Glia|November 26, 2014
Human oligodendrocytes in remyelination researchMarcin Czepiel, Erik Boddeke, Sjef Copray
Frontiers in Aging Neuroscience|January 11, 2020
Insulin-Like Growth Factor-1 Is Neuroprotective in Aged Rats With Ischemic StrokeAhmad Serhan, Erik Boddeke, Ron Kooijman
Glia|March 5, 2014
What is microglia neurotoxicity (Not)?Knut Biber, Trevor Owens, Erik Boddeke
Cellular Reprogramming|October 29, 2010
Ezh2 expression in astrocytes induces their dedifferentiation toward neural stem cellsFalak Sher, Erik Boddeke, Sjef Copray
Stem Cell Reviews and Reports|April 25, 2012
Induced pluripotent stem cell technology and direct conversion: new possibilities to study and treat Parkinson's diseaseReinhard Roessler, Erik Boddeke, Sjef Copray
Stem Cell Reviews and Reports|December 1, 2014
Pluripotent stem cells for Schwann cell engineeringMing-San Ma, Erik Boddeke, Sjef Copray
Glia|January 6, 2015
Immune cell dynamics in the CNS: Learning from the zebrafishNynke Oosterhof, Erik Boddeke, Tjakko J van Ham
Current Opinion in Neurology|September 5, 2008
Oligodendrocyte differentiation and implantation: new insights for remyelinating cell therapyFalak Sher, Veerakumar Balasubramaniyan, Erik Boddeke, et al.
Nature Reviews. Drug Discovery|December 5, 2015
Central nervous system myeloid cells as drug targets: current status and translational challengesKnut Biber, Thomas Möller, Erik Boddeke, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Frontiers in Cellular Neuroscience|August 23, 2014
Neuronal CC chemokines: the distinct roles of CCL21 and CCL2 in neuropathic painKnut Biber, Erik Boddeke
Glia|November 26, 2014
Human oligodendrocytes in remyelination researchMarcin Czepiel, Erik Boddeke, Sjef Copray
Frontiers in Aging Neuroscience|January 11, 2020
Insulin-Like Growth Factor-1 Is Neuroprotective in Aged Rats With Ischemic StrokeAhmad Serhan, Erik Boddeke, Ron Kooijman
Glia|March 5, 2014
What is microglia neurotoxicity (Not)?Knut Biber, Trevor Owens, Erik Boddeke
Cellular Reprogramming|October 29, 2010
Ezh2 expression in astrocytes induces their dedifferentiation toward neural stem cellsFalak Sher, Erik Boddeke, Sjef Copray
Stem Cell Reviews and Reports|April 25, 2012
Induced pluripotent stem cell technology and direct conversion: new possibilities to study and treat Parkinson's diseaseReinhard Roessler, Erik Boddeke, Sjef Copray
Stem Cell Reviews and Reports|December 1, 2014
Pluripotent stem cells for Schwann cell engineeringMing-San Ma, Erik Boddeke, Sjef Copray
Glia|January 6, 2015
Immune cell dynamics in the CNS: Learning from the zebrafishNynke Oosterhof, Erik Boddeke, Tjakko J van Ham
Current Opinion in Neurology|September 5, 2008
Oligodendrocyte differentiation and implantation: new insights for remyelinating cell therapyFalak Sher, Veerakumar Balasubramaniyan, Erik Boddeke, et al.
Nature Reviews. Drug Discovery|December 5, 2015
Central nervous system myeloid cells as drug targets: current status and translational challengesKnut Biber, Thomas Möller, Erik Boddeke, et al.
Pageof 5